ESMCOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends June 30
ESCALON MEDICAL CORP
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Oct 13, 2026
$0.18+0.01 (+7.65%)
Close on Oct 19, 2026
- Market cap
- $2.72M
- P/E (TTM)
- 0.7
- Dividend yield
- –
ESCALON MEDICAL CORP revenue by segment
By business segment
By product or service
| Revenue | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $10.87M | $11.71M | $11.40M | $11.51M | $12.39M | $11.64M | $11.28M | $11.42M | $11.08M | $11.79M | $11.91M | $11.56M | 95.0% | -12.3% |
| Service [Member] | $576.03K | $598.43K | $540.20K | $531.81K | $555.91K | $524.66K | $541.72K | $556.61K | $569.78K | $590.59K | $606.79K | $624.31K | 5.0% | +3.6% |
By region
From the segment and revenue-disaggregation notes of Escalon Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.